Cargando…
Decompensation of cardiorespiratory function and emergence of anemia during pregnancy in a case of mitochondrial myopathy, lactic acidosis, and sideroblastic anemia 2 with compound heterozygous YARS2 pathogenic variants
Myopathy, lactic acidosis, and sideroblastic anemia 2 (MLASA2) is an autosomal recessive mitochondrial disorder caused by pathogenic variants in YARS2. YARS2 variants confer heterogeneous phenotypes ranging from the full MLASA syndrome to a clinically unaffected state. Symptom onset is most common i...
Autores principales: | Rudaks, Laura I., Watson, Eloise, Oboudiyat, Carly, Kumar, Kishore R., Sullivan, Patricia, Cowley, Mark J., Davis, Ryan L., Sue, Carolyn M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541592/ https://www.ncbi.nlm.nih.gov/pubmed/35393742 http://dx.doi.org/10.1002/ajmg.a.62755 |
Ejemplares similares
-
The phenotypic spectrum of germline YARS2 variants: from isolated sideroblastic anemia to mitochondrial myopathy, lactic acidosis and sideroblastic anemia 2
por: Riley, Lisa G., et al.
Publicado: (2018) -
A distinct mitochondrial myopathy, lactic acidosis and sideroblastic anemia (MLASA) phenotype associates with YARS2 mutations
por: Shahni, Rojeen, et al.
Publicado: (2013) -
Phenotypic variability and identification of novel YARS2 mutations in YARS2 mitochondrial myopathy, lactic acidosis and sideroblastic anaemia
por: Riley, Lisa G, et al.
Publicado: (2013) -
Myopathy, lactic acidosis and sideroblastic anemia 1 (MLASA1): A 25-year follow-up
por: Woods, Jeremy, et al.
Publicado: (2019) -
A Myopathy, Lactic Acidosis, Sideroblastic Anemia (MLASA) Case Due to a Novel PUS1 Mutation
por: Kasapkara, Çiğdem Seher, et al.
Publicado: (2017)